Sonida Senior Living, Inc. (SNDA) Stock Price & Analysis
Sonida Senior Living, Inc. (SNDA) closed at USD 33.87 on Thursday, October 22, 2026, up 1.20% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 33.47; the Oct 22, 2026 session ranged USD 33.12–34.05 on volume of 464,756 shares. Market capitalization is $1.63B, with a 52-week range of USD 24.95–44.39 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:25 UTC.
Also available as compact Markdown for AI agents: nexqual.com/SNDA.md
Key facts (SNDA)
- Last four reported quarters (through Jun 30, 2026): revenue $526M, net income -$122M (-23.3% margin), free cash flow -$52.7M (SEC filings).
- 1 of 80 tracked superinvestors hold SNDA (13F, Q2 2026): 1 new, 0 added, 0 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 4 Form 4 filings, $11.0M; 4 not under a Rule 10b5-1 plan ($11.0M); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 1.83 on a 1–5 scale) (6 analysts), mean target USD 49.5 (range 43–65).
- Total return with dividends: 1Y +29.6% vs S&P 500 +14.9%; 5Y +14.1% vs S&P 500 +80.3%.
- Next earnings: 2026-11-05, EPS estimate USD -0.51, revenue estimate $210M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (SNDA)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $235M | $238M | $255M | $304M | $381M | $526M |
| Operating income | — | — | $57.9M | $68.7M | — | — |
| Net income | $126M | -$54.4M | -$21.1M | -$2.1M | -$70.8M | -$122M |
| EPS (diluted) | $37.92 | -$9.27 | -$3.85 | -$0.54 | -$4.22 | — |
| Free cash flow | -$39.2M | -$27.1M | -$7.3M | -$27.0M | -$8.9M | -$52.7M |
| Operating margin | — | — | 22.7% | 22.6% | — | — |
| Net margin | 53.5% | -22.8% | -8.3% | -0.7% | -18.6% | -23.3% |
| Revenue growth | -38.9% | +1.6% | +7.1% | +19.2% | +25.2% | — |
| Cash + short-term investments | $78.7M | $16.9M | $4.1M | $17.0M | $11.0M | — |
| Total debt | $683M | $671M | $629M | $651M | $690M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (SNDA)
P/S 3.1x · EV/Sales 6.0x · P/B 1.9x · FCF yield -3.24% · Earnings yield -7.52% · Net debt $1.52B · EV $3.15B
Superinvestors (SEC 13F-HR, Q2 2026) (SNDA)
1 of 80 tracked investors hold SNDA. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | <0.01% | $2.3M | New position |
Insider sales (SEC Form 4, open-market, last ~7 months) (SNDA)
0 of 4 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-08-28…2026-09-01 | Simanovsky Michael | Director | 123,988 | $4.8M | 1.8% | No | Too little history (no open-market trades in 2023) |
| 2026-08-25…2026-08-27 | Simanovsky Michael | Director | 145,086 | $5.9M | 2% | No | Too little history (no open-market trades in 2023) |
| 2026-08-14 | Harris Benjamin P | Director | 6,269 | $249K | 38.4% | No | Too little history (no open-market trades in 2023 or 2025) |
| 2026-05-13 | Harris Benjamin P | Director | 2,500 | $94K | 21.4% | No | Too little history (no open-market trades in 2023 or 2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (SNDA)
Consensus Buy (mean 1.83 on a 1–5 scale), 6 analysts; mean target USD 49.5 (low 43, high 65).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-04 | Baird | Upgrade | Neutral → Outperform | $37 → $43 |
| 2026-09-01 | Morgan Stanley | Target raised | Equal-Weight | $38 → $44 |
| 2026-08-11 | Cantor Fitzgerald | Target raised | Overweight | $42 → $47 |
| 2026-08-11 | Compass Point | Initiated | Buy | $65 |
| 2026-07-27 | Citizens | Initiated | Market Outperform | $50 |
| 2026-06-29 | RBC Capital | Target raised | Outperform | $45 → $48 |
Total return (dividends reinvested) (SNDA)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +29.6% | +14.1% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +29.7% | +2.7% |
| Volatility (annualized) | 37.3% | 58.8% |
| Max drawdown | -22.3% (Jul 2026→Oct 2026) | -81.3% (Feb 2022→May 2023) |
SNDA analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $-0.51 | $-0.22 | +129.5% | $210.1M | 2 |
| Next quarter (ends Dec 2026) | $-0.47 | $-0.16 | +196.9% | $211.2M | 2 |
| Current fiscal year (ends Dec 2026) | $-3.59 | $-2.97 | +20.9% | $741.5M | 4 |
| Next fiscal year (ends Dec 2027) | $-1.65 | $-0.44 | +275.0% | $871.6M | 2 |
Key Statistics (as of October 23, 2026 at 09:25 UTC)
| Price | USD 33.87 |
|---|---|
| Change | ▲ 1.20% (up) |
| Previous Close | USD 33.47 |
| Open | USD 33.53 |
| Day Range | USD 33.12 – 34.05 |
| 52-Week Range | USD 24.95 – 44.39 |
| Volume | 464,756 shares |
| Market Cap | $1.63B |
| Exchange | NYQ |
Technical Analysis (SNDA)
Nexqual's technical model rates SNDA "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 09:25 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 32.13 (neutral) |
| vs SMA50 | Below (USD 37.8) |
| MACD | -1.13 (negative) |
Analyst Ratings (SNDA)
Wall Street analysts rate SNDA "Buy" based on 6 analysts, with a mean price target of USD 49.5 (range USD 43–65), per Nexqual as of October 23, 2026 at 09:25 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 6 |
| Mean Target | USD 49.5 |
| High Target | USD 65 |
| Low Target | USD 43 |
| Buy / Hold / Sell | 5 / 1 / 0 |
Earnings (SNDA)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD -0.51 |
| Revenue Estimate | $210.11M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.52 vs est -0.48 ▼ miss |
| 2026-03-31 | USD -2.39 vs est -1.47 ▼ miss |
| 2025-12-31 | USD -1.72 vs est -1.3 ▼ miss |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financials & Fundamentals (SNDA)
| Total Revenue | $481.07M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +137.10% |
| Gross Margin | +27.43% |
| Operating Margin | -0.35% |
| Profit Margin | -25.44% |
| ROE | -25.24% |
| Debt / Equity | 1.81 |
| Current Ratio | 0.88 |
| Total Cash | $49.05M |
| Total Debt | $1.57B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | -$52.71M (-10.0% of revenue) |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financial Health Score (SNDA)
Nexqual rates Sonida Senior Living, Inc.'s overall financial health "Weak" across five dimensions, as of October 23, 2026 at 09:25 UTC.
| Growth | Strong — Revenue +25% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 27%, operating -0% (last 12 months) |
| Balance Sheet | Critical — $49M cash and investments vs $1.57B debt (Jun 2026, SEC) |
| Cash Flow | Weak — FCF negative: -$53M (last 4 quarters to Jun 2026, SEC), burning cash |
| Efficiency | Critical — ROE -25%, ROA -0.5% |
Ownership (SNDA)
| Insider Ownership | +8.31% |
|---|---|
| Institutional Ownership | +79.03% |
| Shares Outstanding | 48.05M |
| Float | 27.50M |
| Short % of Float | +11.83% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Leadership (SNDA)
Sonida Senior Living, Inc. is led by Brandon M. Ribar, President, CEO & Director, per Nexqual as of October 23, 2026 at 09:25 UTC.
| President, CEO & Director | Brandon M. Ribar |
|---|---|
| Executive VP & CFO | Kevin J. Detz |
| Executive VP & COO | Anton D. Nikodemus |
| Chief Technology Officer | Jay T. Reed |
| Vice President of Investor Relations | Megan Caldwell |
Major Backers & Investors (SNDA)
Notable institutional backers of Sonida Senior Living, Inc. include Conversant Capital LLC, Capital International Investors, SmallCap World Fund Inc, according to Nexqual as of October 23, 2026 at 09:25 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Conversant Capital LLC | 30.4% |
| Capital International Investors | 6.85% |
| SmallCap World Fund Inc | 6.66% |
| Pertento Partners LLP | 4.94% |
| Irenic Capital Management LP | 3.96% |
| Tyro Capital Management LLC | 1.31% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 4.62% |
| Vanguard Group | 2.68% |
| Geode Capital | 1.55% |
| State Street | 1.29% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CMPS | COMPASS Pathways Plc - American | USD 11.63 | ▼ 1.77% |
| HCSG | Healthcare Services Group, Inc. | USD 24.79 | ▲ 14.19% |
| ARDT | Ardent Health, Inc. | USD 12.36 | ▲ 2.49% |
| AGL | agilon health, inc. | USD 90.29 | ▼ 0.77% |
| PNTG | The Pennant Group, Inc. | USD 42.23 | ▲ 2.9% |
| AMN | AMN Healthcare Services Inc | USD 46.82 | ▲ 8.86% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:25 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt